These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32595431)

  • 1. The Outcome of Hemolytic Disease of the Fetus and Newborn Caused by Anti-Rh17 Antibody: Analysis of Three Cases and Review of the Literature.
    Dajak S; Ipavec N; Cuk M; Golubic Cepulic B; Mratinovic-Mikulandra J; Milardovic J; Stefanovic V
    Transfus Med Hemother; 2020 Jun; 47(3):264-271. PubMed ID: 32595431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfusion management and hemoglobin-based oxygen carrier treatment in a patient with anti-Rh17 antibody.
    Mehr N; Fuja C; Simon C; Carll T; Alkhateb R; Wu S; Patel AA; Aldarweesh F
    Transfusion; 2024 Jun; 64(6):1161-1166. PubMed ID: 38682958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management and clinical consequences of red blood cell antibodies in pregnancy: A population-based cohort study.
    Liu S; Ajne G; Wikman A; Lindqvist C; Reilly M; Tiblad E
    Acta Obstet Gynecol Scand; 2021 Dec; 100(12):2216-2225. PubMed ID: 34476807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful management of fetal hemolytic disease due to strong anti-Rh17 with plasma exchange and intrauterine transfusion in a woman with the D-- phenotype.
    Mimura K; Endo M; Takahashi A; Doi Y; Sakuragi M; Kiyokawa T; Taniguchi H; Kitabatake Y; Handa M; Tomimatsu T; Tomiyama Y; Isaka Y; Kimura T
    Int J Hematol; 2020 Jan; 111(1):149-154. PubMed ID: 31538326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethical Issues and Management of Fetal Hemolytic Anemia Caused by Anti-Rh17 in a Multipara with Rare -D- Phenotype.
    Torreiter PP; Macher S; Matzhold EM; Resch B; Klaritsch P; Körmöczi GF; Polin H; Neuhold L; Schönbacher M; Schlenke P; Wagner T
    Transfus Med Hemother; 2021 May; 48(3):183-187. PubMed ID: 34177424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemolytic disease of the fetus and newborn caused by anti-Hr
    Sarihi R; Ahmadnejad M; Mohammadi S; Eshghi P; Herfat F; Jolharnejad S; Oodi A
    Transfus Apher Sci; 2021 Feb; 60(1):102913. PubMed ID: 32943324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemolytic disease of the fetus and newborn: rapid review of postnatal care and outcomes.
    de Winter DP; Kaminski A; Tjoa ML; Oepkes D; Lopriore E
    BMC Pregnancy Childbirth; 2023 Oct; 23(1):738. PubMed ID: 37853331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal and neonatal outcome in severe alloimmunization managed with intrauterine transfusion: 18-year experience in a tertiary referral hospital in China.
    Pan W; Wu H; Chen J; Mo X; Wang H; Fang Q; Li Y; Huang Y
    Front Pediatr; 2023; 11():1157004. PubMed ID: 37124190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal hemolytic disease due to anti-Rh17 alloimmunization.
    Hirose M; Nakanishi K; Kaku S; Moro H; Hodohara K; Aotani H; Takebayashi K; Noda Y
    Fetal Diagn Ther; 2004; 19(2):182-6. PubMed ID: 14764967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of hemolytic disease of fetus and newborn despite maternal high-titer IgG anti-Ku.
    Kakaiya RM; Whaley A; Howard-Menk C; Rami J; Papari M; Campbell-Lee S; Malecki Z
    Immunohematology; 2010; 26(3):119-23. PubMed ID: 21214298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Red blood cell alloimmunization prevalence and hemolytic disease of the fetus and newborn in Israel: A retrospective study.
    Rahimi-Levene N; Chezar J; Yahalom V;
    Transfusion; 2020 Nov; 60(11):2684-2690. PubMed ID: 32770778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatal hemolytic disease of the fetus and newborn associated with anti-Jr.
    Peyrard T; Pham BN; Arnaud L; Fleutiaux S; Brossard Y; Guerin B; Desmoulins I; Rouger P; Le Pennec PY
    Transfusion; 2008 Sep; 48(9):1906-11. PubMed ID: 18522708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemolytic disease of the fetus and newborn with late-onset anemia due to anti-M: a case report and review of the Japanese literature.
    Yasuda H; Ohto H; Nollet KE; Kawabata K; Saito S; Yagi Y; Negishi Y; Ishida A
    Transfus Med Rev; 2014 Jan; 28(1):1-6. PubMed ID: 24262303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful management of severe red blood cell alloimmunization in pregnancy with a combination of therapeutic plasma exchange, intravenous immune globulin, and intrauterine transfusion.
    Nwogu LC; Moise KJ; Klein KL; Tint H; Castillo B; Bai Y
    Transfusion; 2018 Mar; 58(3):677-684. PubMed ID: 29250791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-C causing severe hemolytic disease of the fetus and newborn: a rare case report.
    Sahoo D; Anuragaa S; Abhishekh B
    Immunohematology; 2023 Apr; 39(1):11-14. PubMed ID: 37017597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful use of maternal blood in the management of severe hemolytic disease of the fetus and newborn due to anti-Kp(b).
    Bleile MJ; Rijhsinghani A; Dwyre DM; Raife TJ
    Transfus Apher Sci; 2010 Dec; 43(3):281-283. PubMed ID: 20951648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal ABO-mismatched blood for intrauterine transfusion of severe hemolytic disease of the newborn due to anti-Rh17.
    Denomme GA; Ryan G; Seaward PG; Kelly EN; Fernandes BJ
    Transfusion; 2004 Sep; 44(9):1357-60. PubMed ID: 15318861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. History and current standard of postnatal management in hemolytic disease of the fetus and newborn.
    De Winter DP; Hulzebos C; Van 't Oever RM; De Haas M; Verweij EJ; Lopriore E
    Eur J Pediatr; 2023 Feb; 182(2):489-500. PubMed ID: 36469119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exchange transfusion of least incompatible blood for severe hemolytic disease of the newborn due to anti-Rh17.
    Li BJ; Jiang YJ; Yuan F; Ye HX
    Transfus Med; 2010 Feb; 20(1):66-9. PubMed ID: 19725902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.